These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20726497)

  • 1. [Amyotrophic lateral sclerosis].
    Veldink JH; Weikamp J; Schelhaas HJ; van den Berg LH
    Ned Tijdschr Tandheelkd; 2010; 117(7-8):380-2. PubMed ID: 20726497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amyotrophic lateral sclerosis. Fatal diagnosis -- how still can be helped?].
    Stiefelhagen P
    MMW Fortschr Med; 2004 Nov; 146(47):16. PubMed ID: 15624649
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognosis in amyotrophic lateral sclerosis: a population-based study.
    Chiò A; Mutani R; Mora G
    Neurology; 2003 Dec; 61(12):1826-7; author reply 1827. PubMed ID: 14694066
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of sporadic amyotrophic lateral sclerosis treated with non-invasive ventilation and riluzole.
    Sívori M; Rodríguez GE; Pascansky D; Sáenz C; Sica RE
    Medicina (B Aires); 2007; 67(4):326-30. PubMed ID: 17891927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amyotrophic lateral sclerosis: update on etiological treatment].
    Ayach L; Curti C; Montana M; Pisano P; Vanelle P
    Therapie; 2013; 68(2):93-106. PubMed ID: 23773350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Riluzole exerts central and peripheral modulating effects in amyotrophic lateral sclerosis.
    Vucic S; Lin CS; Cheah BC; Murray J; Menon P; Krishnan AV; Kiernan MC
    Brain; 2013 May; 136(Pt 5):1361-70. PubMed ID: 23616585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.
    Mandrioli J; Malerba SA; Beghi E; Fini N; Fasano A; Zucchi E; De Pasqua S; Guidi C; Terlizzi E; Sette E; Ravasio A; Casmiro M; Salvi F; Liguori R; Zinno L; Handouk Y; Rizzi R; Borghi A; Rinaldi R; Medici D; Santangelo M; Granieri E; Mussuto V; Aiello M; Ferro S; Vinceti M;
    J Neurol; 2018 Apr; 265(4):817-827. PubMed ID: 29404735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan.
    Lee CT; Chiu YW; Wang KC; Hwang CS; Lin KH; Lee IT; Tsai CP
    J Epidemiol; 2013; 23(1):35-40. PubMed ID: 23117224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
    Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
    Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyotrophic lateral sclerosis: clinical management and research update.
    Andrews J
    Curr Neurol Neurosci Rep; 2009 Jan; 9(1):59-68. PubMed ID: 19080755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amyotrophic lateral sclerosis].
    Iwanowski L
    Neurol Neurochir Pol; 1999; 33(2):445-50. PubMed ID: 10463257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?
    Mitsumoto H; Brooks BR; Silani V
    Lancet Neurol; 2014 Nov; 13(11):1127-1138. PubMed ID: 25316019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular insights and therapeutic targets in amyotrophic lateral sclerosis.
    Tripathi VB; Al-Chalabi A
    CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):11-9. PubMed ID: 18289027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amyotrophic lateral sclerosis. Current clinical trials and underlying pathomechanisms].
    Kollewe K; Dengler R; Petri S
    Nervenarzt; 2008 Jun; 79(6):653-61. PubMed ID: 18210046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical care of patients with amyotrophic lateral sclerosis.
    Radunović A; Mitsumoto H; Leigh PN
    Lancet Neurol; 2007 Oct; 6(10):913-25. PubMed ID: 17884681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis: current practice and future treatments.
    Bedlack RS
    Curr Opin Neurol; 2010 Oct; 23(5):524-9. PubMed ID: 20613515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.